Source:http://linkedlifedata.com/resource/pubmed/id/10447953
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
16
|
pubmed:dateCreated |
1999-9-2
|
pubmed:abstractText |
The synthesis and preliminary evaluation of a novel prodrug approach for improving the water solubility of drugs containing a tertiary amine group are reported. The prodrug synthesis involves a nucleophilic substitution reaction between the parent tertiary amine and a novel derivatizing reagent, di-tert-butyl chloromethyl phosphate, resulting in formation of the quaternary salt. The tertiary butyl groups are easily removed under acidic conditions with trifluoroacetic acid giving the N-phosphonooxymethyl prodrug in the free phosphoric acid form, which can subsequently be converted to the desired salt form. The synthesis was successfully applied to a model compound (quinuclidine) and to three tertiary amine-containing drugs (cinnarizine, loxapine, and amiodarone). The prodrugs were designed to undergo a two-step bioreversion process. The first step was an enzyme-catalyzed rate-determining dephosphorylation followed by spontaneous chemical breakdown of the N-hydroxymethyl intermediate to give the parent drug. Selected prodrugs were shown to be substrates for alkaline phosphatase in vitro. A preliminary in vivo study confirmed the ability of the cinnarizine prodrug to be rapidly and completely converted to cinnarizine in a beagle dog following iv administration.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Alkaline Phosphatase,
http://linkedlifedata.com/resource/pubmed/chemical/Amines,
http://linkedlifedata.com/resource/pubmed/chemical/Cinnarizine,
http://linkedlifedata.com/resource/pubmed/chemical/Loxapine,
http://linkedlifedata.com/resource/pubmed/chemical/Prodrugs,
http://linkedlifedata.com/resource/pubmed/chemical/Quinuclidines
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0022-2623
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
12
|
pubmed:volume |
42
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3094-100
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10447953-Alkaline Phosphatase,
pubmed-meshheading:10447953-Amines,
pubmed-meshheading:10447953-Animals,
pubmed-meshheading:10447953-Chromatography, High Pressure Liquid,
pubmed-meshheading:10447953-Cinnarizine,
pubmed-meshheading:10447953-Dogs,
pubmed-meshheading:10447953-Humans,
pubmed-meshheading:10447953-Injections, Intravenous,
pubmed-meshheading:10447953-Kinetics,
pubmed-meshheading:10447953-Loxapine,
pubmed-meshheading:10447953-Male,
pubmed-meshheading:10447953-Placenta,
pubmed-meshheading:10447953-Prodrugs,
pubmed-meshheading:10447953-Quinuclidines,
pubmed-meshheading:10447953-Solubility
|
pubmed:year |
1999
|
pubmed:articleTitle |
Novel prodrug approach for tertiary amines: synthesis and preliminary evaluation of N-phosphonooxymethyl prodrugs.
|
pubmed:affiliation |
Department of Pharmaceutical Chemistry, The University of Kansas, 2095 Constant Avenue, Lawrence, Kansas 66047, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|